Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Prostate

  • Chapter
Technical Basis of Radiation Therapy

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 2841 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Akazawa PF, Roach M III, Pickett B et al (1996) Three dimensional comparison of blocked arcs vs four and six field conformal treatment of the prostate. Radiother Oncol 1:83–88

    Google Scholar 

  • Algan O, Hanks GE, Shaer AH (1995) Localization of the prostatic apex for radiation treatment planning. Int J Radiat Oncol Biol Phys 33:925–930

    PubMed  CAS  Google Scholar 

  • Allen ZA, Merrick GS, Butler WM et al (2005) Detailed urethral dosimetry in the evaluation of prostate brachytherapy-elated urinary morbidity. Int J Radiat Oncol Biol Phys 2:981–987

    Google Scholar 

  • American Society for Therapeutic Radiology and Oncology Consensus Panel (1997) Consensus statement: guidelines or PSA following radiation therapy. Int J Radiat Oncol Biol hys 37:1035–1041

    Google Scholar 

  • Andriole GL, Ponas SH, Catalona WJ (1992) The implication f focal well differentiated prostate cancer (CaP) in men with elevated serum PSA and palpably normal prostates. J Urol 147:442A

    Google Scholar 

  • Anscher MS, Clough R, Dodge R (2000) Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: he first 10 years. Int J Radiat Oncol Biol Phys 48:369–375

    PubMed  CAS  Google Scholar 

  • Antolak JA, Rosen II, Childress CH et al (1998) Prostate target volume variations during a course of radiotherapy. Int J Radiat Oncol Biol Phys 42:661–672

    PubMed  CAS  Google Scholar 

  • Ash D, Flynn A, Battermann J et al (2000) ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol 57:315–321

    PubMed  CAS  Google Scholar 

  • Badiozamani KR, Wallner K, Cavanagh W et al (1999) Comparability f CT-based and TRUS-based prostate volumes. Int Radiat Oncol Biol Phys 43:375–378

    CAS  Google Scholar 

  • Bagshaw MA, Ray GR, Cox RS (1985) Radiotherapy of prostatic carcinoma: long-or short-term efficacy (Stanford University experience). Urology 25:17–23

    PubMed  CAS  Google Scholar 

  • Bagshaw MA, Cox RS, Ray GR (1988) Status of radiation treatment of prostate cancer at Stanford University. NCI Monogr 7:47–60

    PubMed  Google Scholar 

  • Bastacky SI, Walsh PC, Epstein JI (1993) Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate. Am J Surg Pathol 17:336–341

    PubMed  CAS  Google Scholar 

  • Bayley AJ, Catton CN, Haycocks T et al (2004) A randomized trial of supine vs prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer. Radiother Oncol 70:37–44

    PubMed  Google Scholar 

  • Bellon J, Wallner K, Ellis W et al (1999) Use of pelvic CT scanning to evaluate pubic arch interference of transperineal prostate brachytherapy. Int J Radiat Oncol Biol Phys 43:579–581

    PubMed  CAS  Google Scholar 

  • Biggs PJ, Russell MD (1988) Effect of a femoral head prosthesis on megavoltage beam radiotherapy. Int J Radiat Oncol Biol Phys 14:581–586

    PubMed  CAS  Google Scholar 

  • Blasko JC, Grimm PD, Sylvester JE et al (2000) Palladium-103 brachytherapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 46:839–850

    PubMed  CAS  Google Scholar 

  • Blasko JC, Mate T, Sylvester JE et al (2002) Brachytherapy for carcinoma of the prostate: techniques, patient selection, and clinical outcomes. Semin Radiat Oncol 12:81–94

    PubMed  Google Scholar 

  • Blennerhassett JB, Vickery AL Jr (1966) Carcinoma of the prostate gland. An anatomical study of tumor location. Cancer 19:980–984

    PubMed  CAS  Google Scholar 

  • Bluestein DL, Bostwick DG, Bergstralh EJ et al (1994) Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J Urol 151:1315–1320

    PubMed  CAS  Google Scholar 

  • Boersma LJ, van den Brink M, Bruce AM et al (1998) Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 41:83–92

    PubMed  CAS  Google Scholar 

  • Bolla M, van Poppel H, Collette L et al (2005) Postoperative radiotherapy after radical prostatectomy: a randomized controlled trial (EORTC trial 22911). Lancet 366:572–578

    PubMed  Google Scholar 

  • Bonin SR, Hanlon AL, Lee WR et al (1997) Evidence of increased failure in the treatment of prostate carcinoma patients who have perineural invasion treated with three-dimensional conformal radiation therapy. Cancer 79:75–80

    PubMed  CAS  Google Scholar 

  • Borghede G, Hedelin H, Holmang S et al (1997) Combined treatment with temporary short-term high dose rate iridium-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma. Radiother Oncol 44:237–244

    PubMed  CAS  Google Scholar 

  • Brabbins D, Martinez A, Yan D et al (2005) A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity. Int J Radiat Oncol Biol Phys 61:400–408

    PubMed  Google Scholar 

  • Brenner DJ, Hall EJ (1999) Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 43:1095–1101

    PubMed  CAS  Google Scholar 

  • Brenner DJ, Martinez AA, Edmundson GK et al (2002) Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys 52:6–13

    PubMed  Google Scholar 

  • Breslow N, Chan CW, Dhom G et al (1977) Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France. Int J Cancer 20:680–688

    PubMed  CAS  Google Scholar 

  • Bucci J, Morris WJ, Keyes M et al (2002) Predictive factors of urinary retention following prostate brachytherapy. Int J Radiat Oncol Biol Phys 53:91–98

    PubMed  Google Scholar 

  • Butler WM, Merrick GS, Dorsey AT et al (2000a) Isotope choice and the effect of edema on prostate brachytherapy dosimetry. Med Phys 27:1067–1075

    PubMed  CAS  Google Scholar 

  • Butler WM, Merrick GS, Lief JH et al (2000b) Comparison of seed loading approaches in prostate brachytherapy. Med Phys 27:381–392

    PubMed  CAS  Google Scholar 

  • Cadeddu JA, Partin AW, DeWeese TL et al (1998) Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. J Urol 159:173–178

    PubMed  CAS  Google Scholar 

  • Carrier S, Hricak H, Lee SS et al (1995) Radiation-induced decrease in nitric oxide synthase-containing nerves in the rat penis. Radiology 195:95–99

    PubMed  CAS  Google Scholar 

  • Carter HB, Epstein JI, Partin AW (1999) Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease. Urology 53:126–130

    PubMed  CAS  Google Scholar 

  • Catalona WJ, Bigg SW (1990) Nerve-sparing radical prostatectomy: evaluation of results after 250 patients. J Urol 143:538–544

    PubMed  CAS  Google Scholar 

  • Catalona WJ, Smith DS (1994) 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol 152:1837–1842

    PubMed  CAS  Google Scholar 

  • Cha CM, Potters L, Ashley R et al (1999) Isotope selection for patients undergoing prostate brachytherapy. Int J Radiat Oncol Biol Phys 45:391–395

    PubMed  CAS  Google Scholar 

  • Charyulu KK (1980) Transperineal interstitial implantation of prostate cancer: a new method. Int J Radiat Oncol Biol Phys 6:1261–1266

    PubMed  CAS  Google Scholar 

  • Cheung R, Tucker SL, Dong L et al (2003) Dose-response for biochemical control among high-risk prostate cancer patients after external beam radiotherapy. Int J Radiat Oncol Biol Phys 56:1234–1240

    PubMed  Google Scholar 

  • Chiang PH, Fang FM, Jong WC et al (2004) High-dose rate iridium-192 brachytherapy and external beam radiation therapy for prostate cancer with or without androgen ablation. Int J Urol 11:152–158

    PubMed  Google Scholar 

  • Choi S, Wallner KE, Merrick GS et al (2004) Treatment margins predict biochemical outcomes after prostate brachytherapy. Cancer J 10:175–180

    PubMed  Google Scholar 

  • Clark T, Parekh DJ, Cookson MS et al (2003) Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 169:145–148

    PubMed  Google Scholar 

  • Cox JA, Zagoria RJ, Raben M (1994) Prostate cancer: comparison of retrograde urethrography and computed tomography in radiotherapy planning. Int J Radiat Oncol Biol Phys 29:1119–1123

    PubMed  CAS  Google Scholar 

  • Crook J, Raymond Y, Salhani D et al (1995) Prostate motion during standard radiotherapy as assessed by fiducial markers. Radiother Oncol 37:35–42

    PubMed  CAS  Google Scholar 

  • Crook J, Lukka H, Klotz L et al (2001) Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer. CMAJ 164:975–981

    PubMed  CAS  Google Scholar 

  • Crook J, McLean M, Yeung I et al (2004) MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy. Brachytherapy 3:55–60

    PubMed  Google Scholar 

  • Curran MJ, Healey GA, Bihrle W III et al (2000) Treatment of high-grade low-stage prostate cancer by high-dose-rate brachytherapy. J Endourol 14:351–356

    PubMed  CAS  Google Scholar 

  • D’Amico AV, Whittington R, Malkowicz SB et al (1995) A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. J Urol 154:131–138

    PubMed  CAS  Google Scholar 

  • D’Amico AV, Whittington R, Malkowicz SB et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. J Am Med Assoc 280:969–974

    CAS  Google Scholar 

  • D’Amico AV, Manola J, Loffredo M et al (2004) 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. J Am Med Assoc 292:821–827

    CAS  Google Scholar 

  • Danella JF, deKernion JB, Smith RB et al (1993) The contemporary incidence of lymph node metastases in prostate cancer: implications for laparoscopic lymph node dissection. J Urol 149:1488–1491

    PubMed  CAS  Google Scholar 

  • Dattoli M, Wallner K, True L et al (2003) Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma: influence of prostatic acid phosphatase. Cancer 97:979–983

    PubMed  Google Scholar 

  • Davis BJ, Pisansky TM, Wilson TM et al (1999) The radial distance of extraprostatic extension of prostate carcinoma: implications for prostate brachytherapy. Cancer 85:2630–2637

    PubMed  CAS  Google Scholar 

  • Dawson JE, Wu T, Roy T et al (1994) Dose effects of seeds placement deviations from pre-planned positions in ultrasound guided prostate implants. Radiother Oncol 32:268–270

    PubMed  CAS  Google Scholar 

  • Dawson LA, Litzenberg DW, Brock KK et al (2000) A comparison of ventilatory prostate movement in four treatment positions. Int J Radiat Oncol Biol Phys 48:319–323

    PubMed  CAS  Google Scholar 

  • De Crevoisier R, Tucker SL, Dong L et al (2005) Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 62:965–973

    PubMed  Google Scholar 

  • Deger S, Boehmer D, Turk I et al (2002) High dose rate brachytherapy of localized prostate cancer. Eur Urol 41:420–426

    PubMed  Google Scholar 

  • Del Regato JA, Trailins AH, Pittman DD (1993) Twenty years follow-up of patients with inoperable cancer of the prostate (stage C) treated by radiotherapy: report of a national cooperative study. Int J Radiat Oncol Biol Phys 26:197–201

    PubMed  Google Scholar 

  • Desai J, Stock RG, Stone NN et al (1998) Acute urinary morbidity following I-125 interstitial implantation of the prostate gland. Radiat Oncol Invest 6:135–141

    CAS  Google Scholar 

  • DiBiase SJ, Wallner K, Tralins K et al (2000) Brachytherapy radiation doses to the neurovascular bundles. Int J Radiat Oncol Biol Phys 46:1301–1307

    PubMed  CAS  Google Scholar 

  • Edmundson GK (1994) Volume optimization: an American viewpoint. In: Mould RF et al (eds) Brachytherapy from radium to optimization. Nucletron International, Wageningen, The Netherlands, pp 314–318

    Google Scholar 

  • Epstein JI, Walsh PC, Carmichael M et al (1994) Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. J Am Med Assoc 271:368–374

    CAS  Google Scholar 

  • Fiorino C, Reni M, Cattaneo GM et al (1997) Comparing 3-, 4-and 6-fields techniques for conformal irradiation of prostate and seminal vesicles using dose-volume histograms. Radiother Oncol 44:251–257

    PubMed  CAS  Google Scholar 

  • Fiorino C, Sanguineti G, Cozzarini C et al (2003) Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys 57:953–962

    PubMed  Google Scholar 

  • Fisch BM, Pickett B, Weinberg V et al (2001) Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer. Urology 57:955–959

    PubMed  CAS  Google Scholar 

  • Fowler JF (2005) The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncol 44:265–276

    PubMed  Google Scholar 

  • Fowler J, Chappell R, Ritter M (2001) Is alpha/beta for prostate tumors really low? Int J Radiat Oncol Biol Phys 50:1021–1031

    PubMed  CAS  Google Scholar 

  • Fowler JE Jr, Whitmore WF Jr (1981) The incidence and extent of pelvic lymph node metastases in apparently localized prostatic cancer. Cancer 47:2941–2945

    PubMed  Google Scholar 

  • Fowler JF, Ritter MA, Chappell RJ et al (2003) What hypofractionated protocols should be tested for prostate cancer? Int J Radiat Oncol Biol Phys 56:1093–1104

    PubMed  Google Scholar 

  • Galalae RM, Loch T, Riemer B et al (2004) Health-related quality of life measurement in long-term survivors and outcome following radical radiotherapy for localized prostate cancer. Strahlenther Onkol 180:582–589

    PubMed  Google Scholar 

  • Gelblum DY, Potters L (2000) Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 48:119–124

    PubMed  CAS  Google Scholar 

  • Gelblum DY, Potters L, Ashley R et al (1999) Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys 45:59–67

    PubMed  CAS  Google Scholar 

  • Gervasi LA, Mata J, Easley JD et al (1989) Prognostic significance of lymph nodal metastases in prostate cancer. J Urol 142:332–336

    PubMed  CAS  Google Scholar 

  • Gottschalk AR, Roach M III (2004) The use of hormonal therapy with radiotherapy for prostate cancer: analysis of prospective randomised trials. Br J Cancer 90:950–954

    PubMed  CAS  Google Scholar 

  • Grann A, Wallner K (1998) Prostate brachytherapy in patients with inflammatory bowel disease. Int J Radiat Oncol Biol Phys 40:135–138

    PubMed  CAS  Google Scholar 

  • Gray G, Wallner K, Roof J et al (2000) Cystourethroscopic findings before and after prostate brachytherapy. Tech Urol 6:109–111

    PubMed  CAS  Google Scholar 

  • Grills IS, Martinez AA, Hollander M et al (2004) High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds. J Urol 171:1098–1104

    PubMed  Google Scholar 

  • Gustafson G, Demanes D, Rodriguez R (2003) High dose rate (HDR) monotherapy for early stage prostate cancer: toxicity results utilizing the common toxicity criteria. Int J Radiat Oncol Biol Phys 57:S230–S231

    Google Scholar 

  • Hakenberg OW, Wirth MP, Hermann T et al (2003) Recommendations for the treatment of localized prostate cancer by permanent interstitial brachytherapy. Urol Int 70:15–20

    PubMed  CAS  Google Scholar 

  • Han BH, Demel KC, Wallner K et al (2001a) Patient reported complications after prostate brachytherapy. J Urol 166:953–957

    PubMed  CAS  Google Scholar 

  • Han M, Piantadosi S, Zahurak ML et al (2001b) Serum acid phosphatase level and biochemical recurrence following radical prostatectomy for men with clinically localized prostate cancer. Urology 57:707–711

    PubMed  CAS  Google Scholar 

  • Han BH, Wallner K, Merrick G et al (2003) The effect of interobserver differences in post-implant prostate CT image interpretation on dosimetric parameters. Med Phys 30:1096–1102

    PubMed  Google Scholar 

  • Hanks GE, Lee WR, Hanlon AL et al (1996) Conformal technique dose escalation for prostate cancer: biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen ≧10 ng/ml. Int J Radiat Oncol Biol Phys 35:861–868

    PubMed  CAS  Google Scholar 

  • Heidenreich A, Varga Z, Knobloch R von (2002) Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 167:1681–1686

    PubMed  Google Scholar 

  • Herold DM, Hanlon AL, Movsas B et al (1998) Age-related prostate cancer metastases. Urology 51:985–990

    PubMed  CAS  Google Scholar 

  • Hinerman-Mulroy A, Merrick GS, Butler WM et al (2004) Androgen deprivation-induced changes in prostate anatomy predict urinary morbidity after permanent interstitial brachytherapy. Int J Radiat Oncol Biol Phys 59:1367–1382

    PubMed  Google Scholar 

  • Hiratsuka J, Jo Y, Yoshida K et al (2004) Clinical results of combined treatment conformal high-dose-rate iridium-92 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer. Int J Radiat Oncol Biol Phys 59:684–690

    PubMed  Google Scholar 

  • Howard A, Wallner K, Han B (2001) Clinical course and dosimetry of rectal fistulas after prostate brachytherapy. J Brachyther Int 17:37–42

    Google Scholar 

  • Hsu IC, Lessard E, Weinberg V et al (2004) Comparison of inverse planning simulated annealing and geometrical optimization for prostate high-dose-rate brachytherapy. Brachytherapy 3:147–152

    PubMed  Google Scholar 

  • Huang EH, Pollack A, Levy L et al (2002) Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 54:1314–1321

    PubMed  Google Scholar 

  • Hughes S, Wallner K, Merrick G et al (2001) Preexisting histologic evidence of prostatitis is unrelated to postimplant urinary morbidity. Int J Cancer 96:79–82

    PubMed  CAS  Google Scholar 

  • Hurwitz MD, Schnieder L, Manola J et al (2002) Lack of radiation dose response for patients with low-risk clinically localized prostate cancer: a retrospective analysis. Int J Radiat Oncol Biol Phys 53:1106–1110

    PubMed  Google Scholar 

  • Jackson A, Skwarchuk MW, Zelefsky MJ et al (2001) Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys 49:685–698

    PubMed  CAS  Google Scholar 

  • Jewett HJ (1980) Radical perineal prostatectomy for palpable, clinically localized, non-obstructive cancer: experience at the Johns Hopkins Hospital 1909–1963. J Urol 124:492–494

    PubMed  CAS  Google Scholar 

  • Jo Y, Junichi H, Tomohiro F et al (2005) Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer: effects on health-related quality of life. Br J Urol Int 96:43–47

    Google Scholar 

  • Kattan MW, Zelefsky MJ, Kupelian PA et al (2000) Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. J Clin Oncol 18:3352–3359

    PubMed  CAS  Google Scholar 

  • Kestin L, Goldstein N, Vicini F et al (2002) Treatment of prostate cancer with radiotherapy: Should the entire seminal vesicles be included in the clinical target volume? Int J Radiat Oncol Biol Phys 54:686–697

    PubMed  Google Scholar 

  • Khuntia D, Reddy CA, Mahadevan A et al (2004) Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1–T3 prostate carcinoma in the prostate-specific antigen era: What should we expect? Cancer 100:1283–1292

    PubMed  Google Scholar 

  • Kitamura K, Shirato H, Seppenwoolde Y et al (2002) Three-dimensional intrafractional movement of prostate measured during real-time tumor-tracking radiotherapy in supine and prone treatment positions. Int J Radiat Oncol Biol Phys 53:1117–1123

    PubMed  Google Scholar 

  • Kneebone A, Gebski V, Hogendoorn N et al (2003) A randomized trial evaluating rigid immobilization for pelvic irradiation. Int J Radiat Oncol Biol Phys 56:1105–1111

    PubMed  Google Scholar 

  • Kolkman-Deurloo IK, Visser AG, Niel CG et al (1994) Optimization of interstitial volume implants. Radiother Oncol 31:229–239

    PubMed  CAS  Google Scholar 

  • Koper PC, Heemsbergen WD, Hoogeman MS et al (2004) Impact of volume and location of irradiated rectum wall on rectal blood loss after radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys 58:1072–1082

    PubMed  Google Scholar 

  • Kovacs G, Galalae R (2003) Fractionated perineal high-doserate temporary brachytherapy combined with external beam radiation in the treatment of localized prostate cancer: is lymph node sampling necessary? Cancer Radiother 7:100–106

    PubMed  Google Scholar 

  • Kovacs G, Galalae R, Loch T et al (1999) Prostate preservation by combined external beam and HDR brachytherapy in nodal negative prostate cancer. Strahlenther Onkol 175:87–88

    PubMed  Google Scholar 

  • Kuban DA, Thames HD, Levy LB et al (2003) Long-term multi-institutional analysis of stage T1–T2 prostate cancer treated with radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys 57:915–928

    PubMed  Google Scholar 

  • Kupelian PA, Reddy CA, Carlson TP et al (2002) Dose/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: Absolute or relative rectal volume? Cancer J 8:62–66

    PubMed  Google Scholar 

  • Landis D, Wallner K, Locke J et al (2002) Late urinary function after prostate brachytherapy. Brachytherapy 1:21–26

    PubMed  Google Scholar 

  • Langen KM, Jones DT (2001) Organ motion and its management. Int J Radiat Oncol Biol Phys 50:265–278

    PubMed  CAS  Google Scholar 

  • Lattanzi J, McNeeley S, Pinover W et al (1999) A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer. Int J Radiat Oncol Biol Phys 43:719–725

    PubMed  CAS  Google Scholar 

  • Lattanzi J, McNeeley S, Hanlon A et al (2000) Ultrasoundbased stereotactic guidance of precision conformal external beam radiation therapy in clinically localized prostate cancer. Urology 55:73–78

    PubMed  CAS  Google Scholar 

  • Lawton CA, Winter K, Byhardt R et al (1997) Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85–31). Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 38:931–939

    PubMed  CAS  Google Scholar 

  • Leibel SA, Heimann R, Kutcher GJ et al (1994) Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a phase I dose-escalation study. Int J Radiat Oncol Biol Phys 28:55–65

    PubMed  CAS  Google Scholar 

  • Leibovich BC, Blute ML, Bostwick DG et al (2000a) Proximity of prostate cancer to the urethra: implications for minimally invasive ablative therapies. Urology 56:726–729

    PubMed  CAS  Google Scholar 

  • Leibovich BC, Engen DE, Patterson DE et al (2000b) Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin. J Urol 163:1178–1182

    PubMed  CAS  Google Scholar 

  • Lessard E, Pouliot J (2001) Inverse planning anatomy-based dose optimization for HDR-brachytherapy of the prostate using fast simulated annealing algorithm and dedicated objective function. Med Phys 28:773–779

    PubMed  CAS  Google Scholar 

  • Levegrun S, Jackson A, Zelefsky MJ et al (2002) Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer. Radiother Oncol 63:11–26

    PubMed  Google Scholar 

  • Litzenberg D, Dawson LA, Sandler H et al (2002) Daily prostate targeting using implanted radiopaque markers. Int J Radiat Oncol Biol Phys 52:699–703

    PubMed  Google Scholar 

  • Liu YM, Ling S, Langen KM et al (2004) Prostate movement during simulation resulting from retrograde urethrogram compared with “natural” prostate movement. Int J Radiat Oncol Biol Phys 60:470–475

    PubMed  Google Scholar 

  • Magrini SM, Cellai E, Rossi F et al (1999) Comparison of the conventional “box technique” with two different “conformal” beam arrangements for prostate cancer treatment. Cancer Radiother 3:215–220

    PubMed  CAS  Google Scholar 

  • Malone S, Crook JM, Kendal WS et al (2000) Respiratoryinduced prostate motion: quantification and characterization. Int J Radiat Oncol Biol Phys 48:105–109

    PubMed  CAS  Google Scholar 

  • Mangar SA, Huddart RA, Parker CC et al (2005) Technological advances in radiotherapy for the treatment of localized prostate cancer. Eur J Cancer 41:908–921

    PubMed  Google Scholar 

  • Marsh LH, Ten Haken RK, Sandler HM (1992) A customized non-axial external beam technique for treatment of prostate carcinomas. Med Dosim 17:123–127

    PubMed  CAS  Google Scholar 

  • Martin T, Baltas D, Kurek R et al (2004a) 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study. Strahlenther Onkol 180:225–232

    Google Scholar 

  • Martin T, Roddiger S, Kurek R et al (2004b) 3D conformal HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation in the treatment of localized prostate cancer. Radiother Oncol 71:35–41

    PubMed  Google Scholar 

  • Martinez A, Benson RC, Edmundson GK et al (1985) Pelvic lymphadenectomy combined with transperineal interstitial implantation of iridium-192 and external beam radiotherapy for locally advanced prostatic carcinoma: technical description. Int J Radiat Oncol Biol Phys 11:841–847

    PubMed  CAS  Google Scholar 

  • Martinez A, Pataki I, Edmundson G et al (2001) Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report. Int J Radiat Oncol Biol Phys 49:61–69

    PubMed  CAS  Google Scholar 

  • Martinez A, Gustafson G, Gonzalez J et al (2002) Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer. Int J Radiat Oncol Biol Phys 53:316–327

    PubMed  Google Scholar 

  • Martinez A, Gonzalez J, Spencer W et al (2003) Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors. J Urol 169:974–979

    PubMed  Google Scholar 

  • Martinez A, Demanes DJ, Galalae R et al (2005) Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime. Int J Radiat Oncol Biol Phys 62:1322–1331

    PubMed  Google Scholar 

  • Mate TP, Gottesman JE, Hatton J et al (1998) High dose-rate afterloading 192Iridium prostate brachytherapy: feasibility report. Int J Radiat Oncol Biol Phys 41:525–533

    PubMed  CAS  Google Scholar 

  • McCarthy JF, Catalona WJ, Hudson MA (1994) Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatment. J Urol 151:1575–1578

    PubMed  CAS  Google Scholar 

  • McGowan DG (1981) The value of extended field radiation therapy in carcinoma of the prostate. Int J Radiat Oncol Biol Phys 7:1333–1339

    PubMed  CAS  Google Scholar 

  • McLaughlin PW, Wygoda A, Sahijdak W et al (1999) The effect of patient position and treatment technique in conformal treatment of prostate cancer. Int J Radiat Oncol Biol Phys 45:407–413

    PubMed  CAS  Google Scholar 

  • McLaughlin PW, Troyer S, Berri S et al (2005) Functional anatomy of the prostate: implications for treatment planning. Int J Radiat Oncol Biol Phys 63:479–491

    PubMed  Google Scholar 

  • McNeal JE (1969) Origin and development of carcinoma in the prostate. Cancer 23:24–34

    PubMed  CAS  Google Scholar 

  • Merrick GS, Butler WM (2000) Modified uniform seed loading for prostate brachytherapy: rationale, design, and evaluation. Tech Urol 6:78–84

    PubMed  CAS  Google Scholar 

  • Merrick GS, Butler WM, Dorsey AT et al (1999a) The dependence of prostate postimplant dosimetric quality on CT volume determination. Int J Radiat Oncol Biol Phys 44:1111–1117

    PubMed  CAS  Google Scholar 

  • Merrick GS, Butler WM, Dorsey AT et al (1999b) Potential role of various dosimetric quality indicators in prostate brachytherapy. Int J Radiat Oncol Biol Phys 44:717–724

    PubMed  CAS  Google Scholar 

  • Merrick GS, Butler WM, Lief JH et al (1999c) Efficacy of sildenafil citrate in prostate brachytherapy patients with erectile dysfunction. Urology 53:1112–1116

    PubMed  CAS  Google Scholar 

  • Merrick GS, Butler WM, Dorsey AT et al (2000a) The effect of constipation on rectal dosimetry following prostate brachytherapy. Med Dosim 25:237–241

    PubMed  CAS  Google Scholar 

  • Merrick GS, Butler WM, Dorsey AT et al (2000b) Seed fixity in the prostate/periprostatic region following brachytherapy. Int J Radiat Oncol Biol Phys 46:215–220

    PubMed  CAS  Google Scholar 

  • Merrick GS, Butler WM, Dorsey AT et al (2000c) A comparison of radiation dose to the neurovascular bundles in men with and without prostate brachytherapy-induced erectile dysfunction. Int J Radiat Oncol Biol Phys 48:1069–1074

    PubMed  CAS  Google Scholar 

  • Merrick GS, Butler WM, Lief JH et al (2000d) Temporal resolution of urinary morbidity following prostate brachytherapy. Int J Radiat Oncol Biol Phys 47:121–128

    PubMed  CAS  Google Scholar 

  • Merrick GS, Butler WM, Dorsey AT et al (2001a) Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation. Tech Urol 7:233–240

    PubMed  CAS  Google Scholar 

  • Merrick GS, Butler WM, Galbreath RW et al (2001b) Perineural invasion is not predictive of biochemical outcome following prostate brachytherapy. Cancer J 7:404–412

    PubMed  CAS  Google Scholar 

  • Merrick GS, Butler WM, Galbreath RW et al (2001c) Relationship between the transition zone index of the prostate gland and urinary morbidity after brachytherapy. Urology 57:524–529

    PubMed  CAS  Google Scholar 

  • Merrick GS, Wallner K, Butler WM et al (2001d) A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction. Int J Radiat Oncol Biol Phys 50:597–604

    PubMed  CAS  Google Scholar 

  • Merrick GS, Wallner K, Butler WM et al (2001e) Short-term sexual function after prostate brachytherapy. Int J Cancer 96:313–319

    PubMed  CAS  Google Scholar 

  • Merrick GS, Butler WM, Galbreath RW et al (2002a) Erectile function after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 52:893–902

    PubMed  Google Scholar 

  • Merrick GS, Butler WM, Tollenaar BG et al (2002b) The dosimetry of prostate brachytherapy-induced urethral strictures. Int J Radiat Oncol Biol Phys 52:461–468

    PubMed  Google Scholar 

  • Merrick GS, Butler WM, Wallner K et al (2002c) Permanent prostate brachytherapy-induced morbidity in patients with grade II and III obesity. Urology 60:104–108

    PubMed  Google Scholar 

  • Merrick GS, Butler WM, Wallner KE et al (2002d) Prostate-specific antigen spikes after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 54:450–456

    PubMed  Google Scholar 

  • Merrick GS, Butler WM, Wallner KE et al (2002e) Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy. Urology 60:650–655

    PubMed  Google Scholar 

  • Merrick GS, Butler WM, Galbreath RW et al (2003a) Does hormonal manipulation in conjunction with permanent interstitial brachytherapy, with or without supplemental external beam irradiation, improve the biochemical outcome for men with intermediate or high-risk prostate cancer? Br J Urol Int 91:23–29

    CAS  Google Scholar 

  • Merrick GS, Butler WM, Wallner KE et al (2003b) Extracapsular radiation dose distribution after permanent prostate brachytherapy. Am J Clin Oncol 26:e178–e189

    PubMed  Google Scholar 

  • Merrick GS, Butler WM, Wallner KE et al (2003c) Rectal function following brachytherapy with or without supplemental external beam radiation: results of two prospective randomized trials. Brachytherapy 2:147–157

    PubMed  Google Scholar 

  • Merrick GS, Butler WM, Wallner KE et al (2003d) Long-term urinary quality of life after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 56:454–461

    PubMed  Google Scholar 

  • Merrick GS, Butler WM, Wallner KE et al (2003e) Dysuria after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 55:979–985

    PubMed  Google Scholar 

  • Merrick GS, Butler WM, Wallner KE et al (2003f) Late rectal function after prostate brachytherapy. Int J Radiat Oncol Biol Phys 57:42–48

    PubMed  Google Scholar 

  • Merrick GS, Butler WM, Wallner KE et al (2003g) Prostatespecific antigen (PSA) velocity and benign prostate hypertrophy predict for PSA spikes following prostate brachytherapy. Brachytherapy 2:181–188

    PubMed  Google Scholar 

  • Merrick GS, Wallner KE, Butler WM (2003h) Minimizing prostate brachytherapy-related morbidity. Urology 62:786–792

    PubMed  Google Scholar 

  • Merrick GS, Wallner KE, Butler WM (2003i) Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland. J Urol 169:1643–1652

    PubMed  Google Scholar 

  • Merrick GS, Butler WM, Wallner KE et al (2004a) Effect of transurethral resection on urinary quality of life after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 58:81–88

    PubMed  Google Scholar 

  • Merrick GS, Butler WM, Wallner KE et al (2004b) Permanent interstitial brachytherapy in younger patients with clinically organ-confined prostate cancer. Urology 64:754–759

    PubMed  Google Scholar 

  • Merrick GS, Butler WM, Wallner KE et al (2004c) Temporal effect of neoadjuvant androgen deprivation therapy on PSA kinetics following permanent prostate brachytherapy with or without supplemental external beam radiation. Brachytherapy 3:141–146

    PubMed  Google Scholar 

  • Merrick GS, Butler WM, Wallner KE et al (2004d) Effect of cigarette smoking on biochemical outcome after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 58:1056–1062

    PubMed  CAS  Google Scholar 

  • Merrick GS, Butler WM, Wallner KE et al (2004e) Prognostic significance of percent positive biopsies in clinically organ-confined prostate cancer treated with permanent prostate brachytherapy with or without supplemental external-beam radiation. Cancer J 10:54–60

    PubMed  Google Scholar 

  • Merrick GS, Wallner KE, Butler WM (2004f) Patient selection for prostate brachytherapy: more myth than fact. Oncology (Williston Park) 18:445–452, 455–-457

    Google Scholar 

  • Merrick GS, Butler WM, Wallner KE et al (2005a) Influence of body mass index on biochemical outcome after permanent prostate brachytherapy. Urology 65:95–100

    PubMed  Google Scholar 

  • Merrick GS, Butler WM, Wallner KE et al (2005b) Erectile function after prostate brachytherapy. Int J Radiat Oncol Biol Phys 62:437–447

    PubMed  Google Scholar 

  • Merrick GS, Butler WM, Wallner KE et al (2005c) Variability of prostate brachytherapy preimplant dosimetry. A multi institution analysis. Brachytherapy 4:241–251

    PubMed  Google Scholar 

  • Michalski JM, Purdy JA, Winter K et al (2000) Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys 46:391–402

    PubMed  CAS  Google Scholar 

  • Michalski JM, Winter K, Purdy JA et al (2004) Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV. Int J Radiat Oncol Biol Phys 58:735–742

    PubMed  Google Scholar 

  • Michalski JM, Winter K, Purdy JA et al (2005) Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V. Int J Radiat Oncol Biol Phys 62:706–713

    PubMed  Google Scholar 

  • Middleton RG (1988) Value of and indications for pelvic lymph node dissection in the staging of prostate cancer. NCI Monogr 7:41–43

    PubMed  Google Scholar 

  • Moreland RB (1998) Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence. Int J Impot Res 10:113–120

    PubMed  CAS  Google Scholar 

  • Morton GC (2005) The emerging role of high-dose-rate brachytherapy for prostate cancer. Clin Oncol (R Coll Radiol) 17:219–227

    CAS  Google Scholar 

  • Mueller A, Wallner K, Merrick G et al (2004) Perirectal seeds as a risk factor for prostate brachytherapy-related rectal bleeding. Int J Radiat Oncol Biol Phys 59:1047–1052

    PubMed  Google Scholar 

  • Mulhall JP (2001) Minimizing radiation-induced erectile dysfunction. J Brachyther Int 17:221–227

    Google Scholar 

  • Myers RP, Goellner JR, Cahill DR (1987) Prostate shape, external striated urethral sphincter and radical prostatectomy: the apical dissection. J Urol 138:543–550

    PubMed  CAS  Google Scholar 

  • Nag S, Beyer D, Friedland J et al (1999) American brachytherapy society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys 44:789–799

    PubMed  CAS  Google Scholar 

  • Narayan P, Fournier G, Gajendran V et al (1994) Utility of preoperative serum prostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer. Urology 44:519–524

    PubMed  CAS  Google Scholar 

  • Nilsson S, Norlen BJ, Widmark A (2004) A systematic overview of radiation therapy effects in prostate cancer. Acta Oncol 43:316–381

    PubMed  Google Scholar 

  • Noguchi M, Stamey TA, Neal JE et al (2000) An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics. J Urol 163:1751–1755

    PubMed  CAS  Google Scholar 

  • Nudell DM, Grossfeld GD, Weinberg VK et al (1999) Radiotherapy after radical prostatectomy: treatment outcomes and failure patterns. Urology 54:1049–1057

    PubMed  CAS  Google Scholar 

  • Nutting CM, Khoo VS, Walker V et al (2000) A randomized study of the use of a customized immobilization system in the treatment of prostate cancer with conformal radiotherapy. Radiother Oncol 54:1–9

    PubMed  CAS  Google Scholar 

  • Oelrich TM (1980) The urethral sphincter muscle in the male. Am J Anat 158:229–246

    PubMed  CAS  Google Scholar 

  • Oesterling JE, Suman VJ, Zincke H (1994) PSA-detected 9clinical state T1c or B1 prostate cancer. Urol Clin North Am 20:293–302

    Google Scholar 

  • Ohori M, Wheeler TM, Kattan MW et al (1995) Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 154:1818–1824

    PubMed  CAS  Google Scholar 

  • Parker CC, Damyanovich A, Haycocks T et al (2003) Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration. Radiother Oncol 66:217–224

    PubMed  CAS  Google Scholar 

  • Partin AW, Yoo J, Carter HB et al (1993) The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150:110–114

    PubMed  CAS  Google Scholar 

  • Partin AW, Kattan MW, Subong EN et al (1997) Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. J Am Med Assoc 277:1445–1451

    CAS  Google Scholar 

  • Partin AW, Mangold LA, Lamm DM et al (2001) Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 58:843–848

    PubMed  CAS  Google Scholar 

  • Patel RR, Orton N, Tome WA et al (2003) Rectal dose sparing with a balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer. Radiother Oncol 67:285–294

    PubMed  Google Scholar 

  • Pedley ID (2002) Transperineal interstitial permanent prostate brachytherapy for carcinoma of the prostate. Surg Oncol 11:25–34

    PubMed  Google Scholar 

  • Pellizzon AC, Nadalin W, Salvajoli JV et al (2003) Results of high dose rate afterloading brachytherapy boost to conventional external beam radiation therapy for initial and locally advanced prostate cancer. Radiother Oncol 66:167–172

    PubMed  Google Scholar 

  • Pellizzon AC, Salvajoli JV, Maia MA et al (2004) Late urinary morbidity with high dose prostate brachytherapy as a boost to conventional external beam radiation therapy for local and locally advanced prostate cancer. J Urol 171:1105–1108

    PubMed  Google Scholar 

  • Perez CA (1983) Presidential address of the 24th annual meeting of the American Society of Therapeutic Radiologists: carcinoma of the prostate, a vexing biological and clinical enigma. Int J Radiat Oncol Biol Phys 9:1427–1438

    PubMed  CAS  Google Scholar 

  • Perez CA (1998) Prostate. In: Brady LW (eds) Principles and practice of radiation oncology. Lippincott Raven, Philadelphia, pp 1583–1694

    Google Scholar 

  • Perez CA, Pilepich MV, Garcia D et al (1988) Definitive radiation therapy in carcinoma of the prostate localized to the pelvis: experience at the Mallinckrodt Institute of Radiology. NCI Monogr 7:85–94

    PubMed  Google Scholar 

  • Perez CA, Lee HK, Georgiou A et al (1993) Technical and tumor-related factors affecting outcome of definitive irradiation for localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys 26:581–591

    PubMed  CAS  Google Scholar 

  • Perez CA, Michalski J, Ballard S et al (1997) Cost benefit of emerging technology in localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys 39:875–883

    PubMed  CAS  Google Scholar 

  • Perrotti M, Kaufman RP, Jr., Jennings TA et al (1996) Endorectal coil magnetic resonance imaging in clinically localized prostate cancer: Is it accurate? J Urol 156:106–109

    PubMed  CAS  Google Scholar 

  • Pisansky TM, Blute ML, Suman VJ et al (1996a) Correlation of pretherapy prostate cancer characteristics with seminal vesicle invasion in radical prostatectomy specimens. Int J Radiat Oncol Biol Phys 36:585–591

    PubMed  CAS  Google Scholar 

  • Pisansky TM, Zincke H, Suman VJ et al (1996b) Correlation of pretherapy prostate cancer characteristics with histologic findings from pelvic lymphadenectomy specimens. Int J Radiat Oncol Biol Phys 34:33–39

    PubMed  CAS  Google Scholar 

  • Pistenma DA, Bagshaw MA, Freiha FS (1979) Extended-field radiation therapy for prostatic adenocardinoma: status report of a limited prospective trial. In: Samuels ML (ed) Cancer of the genitourinary tract. Raven, New York, pp 229–247

    Google Scholar 

  • Pollack A, Smith LG, von Eschenbach AC (2000) External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era. Int J Radiat Oncol Biol Phys 48:507–512

    PubMed  CAS  Google Scholar 

  • Pollack A, Zagars GK, Starkschall G et al (2002) Prostate cancer radiation dose response: results of the MD Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53:1097–1105

    PubMed  Google Scholar 

  • Pollack A, Hanlon AL, Horwitz EM et al (2004) Prostate cancer radiotherapy dose response: an update of the fox chase experience. J Urol 171:1132–1136

    PubMed  Google Scholar 

  • Potters L, Torre T, Ashley R et al (2000) Examining the role of neoadjuvant androgen deprivation in patients undergoing prostate brachytherapy. J Clin Oncol 18:1187–1192

    PubMed  CAS  Google Scholar 

  • Potters L, Torre T, Fearn PA et al (2001) Potency after permanent prostate brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 50:1235–1242

    PubMed  CAS  Google Scholar 

  • Poulos CK, Daggy JK, Cheng L (2004) Prostate needle biopsies: multiple variables are predictive of final tumor volume in radical prostatectomy specimens. Cancer 101:527–532

    PubMed  Google Scholar 

  • Prete JJ, Prestidge BR, Bice WS et al (1998) A survey of physics and dosimetry practice of permanent prostate brachytherapy in the United States. Int J Radiat Oncol Biol Phys 40:1001–1005

    PubMed  CAS  Google Scholar 

  • Rasch C, Barillot I, Remeijer P et al (1999) Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys 43:57–66

    PubMed  CAS  Google Scholar 

  • Reed D, Wallner K, Merrick G et al (2003) Clinical correlates to PSA spikes and positive repeat biopsies after prostate brachytherapy. Urology 62:683–688

    PubMed  Google Scholar 

  • Roach M III (1993) Re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150:1923–1924

    PubMed  Google Scholar 

  • Roach M III, Akazawa PF, Pickett B et al (1994) Bilateral arcs using “averaged beam’s eye views”: a simplified technique for delivering 3-D based conformal radiotherapy. Med Dosim 19:159–168

    PubMed  Google Scholar 

  • Roach M III, Faillace-Akazawa P, Malfatti C (1997) Prostate volumes and organ movement defined by serial computerized tomographic scans during three-dimensional conformal radiotherapy. Radiat Oncol Invest 5:187–194

    Google Scholar 

  • Roach M III, DeSilvio M, Lawton C et al (2003) Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol 21:1904–1911

    PubMed  Google Scholar 

  • Roach M, Winter K, Michalski JM et al (2004) Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study. Int J Radiat Oncol Biol Phys 60:1351–1356

    PubMed  Google Scholar 

  • Roberson PL, Narayana V, McShan DL et al (1997) Source placement error for permanent implant of the prostate. Med Phys 24:251–257

    PubMed  CAS  Google Scholar 

  • Rosenthal SA, Roach M III, Goldsmith BJ et al (1993) Immobilization improves the reproducibility of patient positioning during six-field conformal radiation therapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 27:921–926

    PubMed  CAS  Google Scholar 

  • Rukstalis DB, Lawton CA, Brendler CB (1996) Management options for patients with lymph node metastases from prostate cancer. In: Shipley WU (ed) Comprehensive textbook of genitourinary oncology. Williams and Wilkins, Baltimore, pp 838–853

    Google Scholar 

  • Ryu JK, Winter K, Michalski JM (2001) Preliminary report of toxicity following 3D conformal radiation therapy (3DCRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy). Int J Radiat Oncol Biol Phys 51:136–137

    Google Scholar 

  • Sadeghi A, Kuisk H, Tran L et al (1996) Urethrography and ischial intertuberosity line in radiation therapy planning for prostate carcinoma. Radiother Oncol 38:215–222

    PubMed  CAS  Google Scholar 

  • Sandler H, Michalski J (2005) Treatment of early stage prostate cancer: 3D conformal radiotherapy for localized prostate cancer. In: Vogelzang NJ, Scardino PT, Shipley WU, Debruyne FMJ, Linehan WM (eds) Comprehensive textbook of genitourinary oncology, 3rd edn. Lippincott, Williams and Wilkins, Philadelpphia, pp 203–217

    Google Scholar 

  • Sathya JR, Davis IR, Julian JA et al (2005) Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate. J Clin Oncol 23:1192–1199

    PubMed  Google Scholar 

  • Selek U, Lee A, Levy L et al (2003) Utility of the percentage of positive prostate biopsies in predicting PSA outcome after radiotherapy for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 57:963–967

    PubMed  Google Scholar 

  • Sherertz T, Wallner K, Wang H et al (2001) Long-term urinary function after transperineal brachytherapy for patients with large prostate glands. Int J Radiat Oncol Biol Phys 51:1241–1245

    PubMed  CAS  Google Scholar 

  • Smith CV, Bauer JJ, Connelly RR et al (2000) Prostate cancer in men age 50 years or younger: a review of the Department of Defense Center for Prostate Disease Research multicenter prostate cancer database. J Urol 164:1964–1967

    PubMed  CAS  Google Scholar 

  • Snyder KM, Stock RG, Hong SM et al (2001) Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 50:335–341

    PubMed  CAS  Google Scholar 

  • Soffen EM, Hanks GE, Hwang CC et al (1991) Conformal static field therapy for low volume low grade prostate cancer with rigid immobilization. Int J Radiat Oncol Biol Phys 20:141–146

    PubMed  CAS  Google Scholar 

  • Sohayda C, Kupelian PA, Levin HS et al (2000) Extent of extracapsular extension in localized prostate cancer. Urology 55:382–386

    PubMed  CAS  Google Scholar 

  • Spevack L, Killion LT, West JC Jr et al (1996) Predicting the patient at low risk for lymph node metastasis with localized prostate cancer: an analysis of four statistical models. Int J Radiat Oncol Biol Phys 34:543–547

    PubMed  CAS  Google Scholar 

  • Steenbakkers RJ, Deurloo KE, Nowak PJ et al (2003) Reduction of dose delivered to the rectum and bulb of the penis using MRI delineation for radiotherapy of the prostate. Int J Radiat Oncol Biol Phys 57:1269–1279

    PubMed  Google Scholar 

  • Stephenson AJ, Shariat SF, Zelefsky MJ et al (2004) Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. J Am Med Assoc 291:1325–1332

    CAS  Google Scholar 

  • Stock RG, Stone NN, Ianuzzi C et al (1995) Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer. Int J Radiat Oncol Biol Phys 33:815–821

    PubMed  CAS  Google Scholar 

  • Stock RG, Stone NN, Tabert A et al (1998) A dose-response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys 41:101–108

    PubMed  CAS  Google Scholar 

  • Stock RG, Kao J, Stone NN (2001) Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. J Urol 165:436–439

    PubMed  CAS  Google Scholar 

  • Stone NN, Stock RG (2000) Prostate brachytherapy in patients with prostate volumes ≥50 cm(3): dosimetic analysis of implant quality. Int J Radiat Oncol Biol Phys 46:1199–1204

    PubMed  CAS  Google Scholar 

  • Stone NN, Stock RG (2002) Complications following permanent prostate brachytherapy. Eur Urol 41:427–433

    PubMed  CAS  Google Scholar 

  • Stone NN, Stock RG, Unger P (1995) Indications for seminal vesicle biopsy and laparoscopic pelvic lymph node dissection in men with localized carcinoma of the prostate. J Urol 154:1392–1396

    PubMed  CAS  Google Scholar 

  • Stone NN, Ratnow ER, Stock RG (2000) Prior transurethral resection does not increase morbidity following real-time ultrasound-guided prostate seed implantation. Tech Urol 6:123–127

    PubMed  CAS  Google Scholar 

  • Storey MR, Pollack A, Zagars G et al (2000) Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 48:635–642

    PubMed  CAS  Google Scholar 

  • Syed AM, Puthawala A, Transey LA (1983) Temporary iridium-192 implantation in the management of carcinoma of the prostate. Memorial Sloan-Kettering Cancer Center, New York

    Google Scholar 

  • Syed AM, Puthawala A, Sharma A et al (2001) High-dose-rate brachytherapy in the treatment of carcinoma of the prostate. Cancer Control 8:511–521

    PubMed  CAS  Google Scholar 

  • Symon Z, Griffith KA, McLaughlin PW et al (2003) Dose escalation for localized prostate cancer: substantial benefit observed with 3D conformal therapy. Int J Radiat Oncol Biol Phys 57:384–390

    PubMed  Google Scholar 

  • Talcott JA, Clark JA, Stark PC et al (2001) Long-term treatment related complications of brachytherapy for early prostate cancer: a survey of patients previously treated. J Urol 166:494–499

    PubMed  CAS  Google Scholar 

  • Taylor WJ, Richardson RG, Hafermann MD (1979) Radiation therapy for localized prostate cancer. Cancer 43:1123–1127

    PubMed  CAS  Google Scholar 

  • Teh BS, McGary JE, Dong L et al (2002) The use of rectal balloon during the delivery of intensity modulated radiotherapy (IMRT) for prostate cancer: More than just a prostate gland immobilization device? Cancer J 8:476–483

    PubMed  Google Scholar 

  • Teh BS, Bastasch MD, Mai WY et al (2003) Predictors of extracapsular extension and its radial distance in prostate cancer: implications for prostate IMRT, brachytherapy, and surgery. Cancer J 9:454–460

    PubMed  Google Scholar 

  • Ten Haken RK, Perez-Tamayo C, Tesser RJ et al (1989) Boost treatment of the prostate using shaped, fixed fields. Int J Radiat Oncol Biol Phys 16:193–200

    PubMed  Google Scholar 

  • Terk MD, Stock RG, Stone NN (1998) Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol 160:1379–1382

    PubMed  CAS  Google Scholar 

  • Thomas MD, Cormack R, Tempany CM et al (2000) Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy. Int J Radiat Oncol Biol Phys 47:905–908

    PubMed  CAS  Google Scholar 

  • Tinger A, Michalski JM, Cheng A et al (1998) A critical evaluation of the planning target volume for 3-D conformal radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys 42:213–221

    PubMed  CAS  Google Scholar 

  • Valicenti RK, Gomella LG, Ismail M et al (1998) Effect of higher radiation dose on biochemical control after radical prostatectomy for PT3N0 prostate cancer. Int J Radiat Oncol Biol Phys 42:501–506

    PubMed  CAS  Google Scholar 

  • Valicenti RK, Gomella LG, Ismail M et al (1999) The efficacy of early adjuvant radiation therapy for pT3N0 prostate cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys 45:53–58

    PubMed  CAS  Google Scholar 

  • Van Herk M, Bruce A, Kroes AP et al (1995) Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. Int J Radiat Oncol Biol Phys 33:1311–1320

    PubMed  Google Scholar 

  • Vicini FA, Martinez A, Hanks G et al (2002) An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow-up. Cancer 95:2126–2135

    PubMed  Google Scholar 

  • Vigneault E, Pouliot J, Laverdiere J et al (1997) Electronic portal imaging device detection of radioopaque markers for the evaluation of prostate position during megavoltage irradiation: a clinical study. Int J Radiat Oncol Biol Phys 37:205–212

    PubMed  CAS  Google Scholar 

  • Villeirs GM, Verstraete KL, de Neve WJ et al (2005) Magnetic resonance imaging anatomy of the prostate and periprostatic area: a guide for radiotherapists. Radiother Oncol 76:99–106

    PubMed  Google Scholar 

  • Villers AA, McNeal JE, Freiha FS et al (1991) Development of prostatic carcinoma. Morphometric and pathologic features of early stages. Acta Oncol 30:145–151

    PubMed  CAS  Google Scholar 

  • Wachter S, Gerstner N, Dorner D et al (2002) The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 52:91–100

    PubMed  Google Scholar 

  • Wahlgren T, Brandberg Y, Haggarth L et al (2004) Healthrelated quality of life in men after treatment of localized prostate cancer with external beam radiotherapy combined with (192)ir brachytherapy: a prospective study of 93 cases using the EORTC questionnaires QLQ-C30 and QLQ-PR25. Int J Radiat Oncol Biol Phys 60:51–59

    PubMed  Google Scholar 

  • Wallner K, Roy J, Harrison L (1995) Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 32:465–471

    PubMed  CAS  Google Scholar 

  • Wallner K, Lee H, Wasserman S et al (1997) Low risk of urinary incontinence following prostate brachytherapy in patients with a prior transurethral prostate resection. Int J Radiat Oncol Biol Phys 37:565–569

    PubMed  CAS  Google Scholar 

  • Wallner K, Smathers S, Sutlief S et al (2000) Prostate brachytherapy in patients with median lobe hyperplasia. Int J Cancer 90:152–156

    PubMed  CAS  Google Scholar 

  • Wallner K, Merrick G, True L et al (2002a) I-125 versus Pd-103 for low-risk prostate cancer: morbidity outcomes from a prospective randomized multicenter trial. Cancer J 8:67–73

    PubMed  Google Scholar 

  • Wallner K, Merrick GS, Benson ML et al (2002b) Penile bulb imaging. Int J Radiat Oncol Biol Phys 53:928–933

    PubMed  Google Scholar 

  • Wallner K, Merrick G, True L et al (2003) 125I versus 103Pd for low-risk prostate cancer: preliminary PSA outcomes from a prospective randomized multicenter trial. Int J Radiat Oncol Biol Phys 57:1297–1303

    PubMed  Google Scholar 

  • Waterman FM, Dicker AP (1999) Effect of post-implant edema on the rectal dose in prostate brachytherapy. Int J Radiat Oncol Biol Phys 45:571–576

    PubMed  CAS  Google Scholar 

  • Waterman FM, Yue N, Corn BW et al (1998) Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition. Int J Radiat Oncol Biol Phys 41:1069–1077

    PubMed  CAS  Google Scholar 

  • Wawroschek F, Wagner T, Hamm M et al (2003) The influence of serial sections, immunohistochemistry, and extension of pelvic lymph node dissection on the lymph node status in clinically localized prostate cancer. Eur Urol 43:132–137

    PubMed  Google Scholar 

  • Weber DC, Nouet P, Rouzaud M et al (2000) Patient positioning in prostate radiotherapy: Is prone better than supine? Int J Radiat Oncol Biol Phys 47:365–371

    PubMed  CAS  Google Scholar 

  • Wiegel T, Bottke D, Willich N (2005) Phase III results of adjuvant radiotherapy (RT) versus “wait and see” (WS) in patients with pT3 prostate cancer following radical prostatectomy (RP). ASCO, Orlando, Florida

    Google Scholar 

  • Wilder RB, Fone PD, Rademacher DE et al (1997) Localization of the prostatic apex for radiotherapy treatment planning using urethroscopy. Int J Radiat Oncol Biol Phys 38:737–741

    PubMed  CAS  Google Scholar 

  • Wilson LD, Ennis R, Percarpio B et al (1994) Location of the prostatic apex and its relationship to the ischial tuberosities. Int J Radiat Oncol Biol Phys 29:1133–1138

    PubMed  CAS  Google Scholar 

  • Wise AM, Stamey TA, McNeal JE et al (2002) Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology 60:264–269

    PubMed  Google Scholar 

  • Yan D, Lockman D, Brabbins D et al (2000) An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer. Int J Radiat Oncol Biol Phys 48:289–302

    PubMed  CAS  Google Scholar 

  • Yoshioka Y, Nose T, Yoshida K et al (2000) High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial. Int J Radiat Oncol Biol Phys 48:675–681

    PubMed  CAS  Google Scholar 

  • Yoshioka Y, Nishimura T, Kamata M et al (2005) Evaluation of anatomy-based dwell position and inverse optimization in high-dose-rate brachytherapy of prostate cancer: a dosimetric comparison to a conventional cylindrical dwell position, geometric optimization, and dose-point optimization. Radiother Oncol 75:311–317

    PubMed  Google Scholar 

  • Zelefsky MJ, Aschkenasy E, Kelsen S et al (1997a) Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 39:327–333

    PubMed  CAS  Google Scholar 

  • Zelefsky MJ, Happersett L, Leibel SA et al (1997b) The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 37:13–19

    PubMed  CAS  Google Scholar 

  • Zelefsky MJ, Crean D, Mageras GS et al (1999) Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy. Radiother Oncol 50:225–234

    PubMed  CAS  Google Scholar 

  • Zelefsky MJ, Fuks Z, Hunt M et al (2001) High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 166:876–881

    PubMed  CAS  Google Scholar 

  • Zelefsky MJ, Fuks Z, Hunt M et al (2002) High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 53:1111–1116

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Washington University School of Medicine, 4921 Parkview Place, St. Louis, MO, 63110, USA

    Jeff M. Michalski MD, MBA (Associate Professor in Radiation Oncology)

  2. Schiffler Cancer Center and Wheeling Jesuit University, Wheeling, WV, 26003, USA

    Gregory S. Merrick MD

  3. Institution for Oncology Pathology, Karolinska University Hospital, 17176, Stockholm, Sweden

    Sten Nilsson MD, PhD (Profesor)

Authors
  1. Jeff M. Michalski MD, MBA
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gregory S. Merrick MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sten Nilsson MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Therapeutic Radiation, Oncology MMC 436, University of Minnesota Hospital, 420 Delaware St SE, Minneapolis, MN, 55455, USA

    Seymour H. Levitt MD (Professor and Foreign Adjunct Professor) (Professor and Foreign Adjunct Professor)

  2. Karolinska Institute Stockholm, Sweden

    Seymour H. Levitt MD (Professor and Foreign Adjunct Professor) (Professor and Foreign Adjunct Professor)

  3. Department of Radiation Oncology, UC Davis Medical Center, 4501 X Street, Suite G140, Sacramento, CA, 95817, USA

    James A. Purdy PhD (Professor, Vice Chairman and Chief) (Professor, Vice Chairman and Chief)

  4. Physics Section, UC Davis Medical Center, 4501 X Street, Suite G140, Sacramento, CA, 95817, USA

    James A. Purdy PhD (Professor, Vice Chairman and Chief) (Professor, Vice Chairman and Chief)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Michalski, J.M., Merrick, G.S., Nilsson, S. (2006). Prostate. In: Levitt, S.H., Purdy, J.A. (eds) Technical Basis of Radiation Therapy. Medical Radiology. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-35665-7_28

Download citation

  • DOI: https://doi.org/10.1007/3-540-35665-7_28

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-21338-3

  • Online ISBN: 978-3-540-35665-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation